SCHEMBL8869486

SCHEMBL8869486

CCCOC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(Cl)cc3)cc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.49
EGFR P00533 1/20 0.47
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
CA2 P00918 3/20 0.43
CA1 P00915 2/20 0.43
CA9 Q16790 2/20 0.43
CA7 P43166 1/20 0.43
CA14 Q9ULX7 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
BCL2L1 Q07817 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869230 1.00 PPARA (0.49) PPARAEGFRNPC1RAB9AMEN1
SCHEMBL8868748 0.93 NPC1 (0.49) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8869126 0.93 PPARA (0.51) PPARAEGFRNPC1RAB9AMEN1
SCHEMBL8869124 0.93 MAPT (0.48) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8868674 0.93 MAPT (0.48) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8868835 0.92 NPC1 (0.52) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8869220 0.92 P4HTM (0.54) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8868673 0.92 POLB (0.49) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8868336 0.91 P4HTM (0.44) PPARAEGFRNPC1RAB9AMEN1
SCHEMBL9140560 0.91 PPARA (0.49) PPARAEGFRNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed